Pancreatic cancer is the fourth leading cause of cancer-related death in the U.S. in both men and women. It typically presents at an advanced, incurable stage. Identifying and testing individuals with an elevated risk for developing pancreatic cancer may lead to improved outcomes.
Currently there are no standardized recommendations for screening individuals who have an elevated risk for pancreatic cancer. White Plains Hospital offers a clinical trial that follows the outcomes of elevated risk individuals who undergo early detection testing, using the most modern and up-to-date testing methods, and employing the most advanced options for elevated risk.
- Have an immediate family member under the age of 50, or multiple family members, who have had pancreatic cancer?
- Carry a BRCA2 gene mutation?
- Carry a p16 gene mutation for Familial Atypical Multiple Mole Melanoma?
- Carry a BRCA1 gene mutation AND have family members with pancreatic cancer?
- Carry a gene mutation for other cancers (including colon cancer) AND have family members with pancreatic cancer?
- Have Peutz-Jeghers Syndrome?
- Have Chronic Pancreatitis Syndrome?
- Have other risk factors for the development of pancreatic cancer?
If you answered YES to ANY of these questions, then you may be eligible to undergo testing to screen for pancreatic cancer and enroll into this clinical trial. See below for more information on enrollment.
Call our research coordinator at 914-849-7667